KL
CATX icon

KilterHowling LLC’s Perspective Therapeutics CATX Stock Holding History

KilterHowling LLC’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,463
Closed -$4K – 50
2023
Q3 		$4K Hold
1,463
– – ﹤0.01% 48
2023
Q2 		$9.77K Buy
+1,463
New +$8.88K 0.01% 54

Other funds holding CATX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RAG
RIA Advisory Group Des Moines, Iowa $421M AUM 30.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
OCM
Osterweis Capital Management San Francisco, California $1.94B AUM 20.77% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KilterHowling LLC's CATX Position: Q4 2023 in Review

KilterHowling LLC sold out of Perspective Therapeutics (CATX) in Q4 2023, closing a stake of 1,463 shares — an estimated $4K sold.

KilterHowling LLC first reported a position in CATX in Q2 2023 and held it in 2 quarters. The position peaked at $9.77K in Q2 2023. 52 funds tracked by Wall St. Rank hold CATX as of Q4 2023.

  • KilterHowling LLC reported no remaining Perspective Therapeutics position as of Q4 2023 after selling out during the quarter.
  • KilterHowling LLC sold 1,463 Perspective Therapeutics shares in Q4 2023, an estimated $4K.
  • KilterHowling LLC first reported a position in Perspective Therapeutics in Q2 2023 and held it in 2 quarters.
  • KilterHowling LLC's Perspective Therapeutics position peaked at $9.77K in Q2 2023.
  • 52 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q4 2023.

Based on KilterHowling LLC's 13F filing for Q4 2023, filed 8 Feb 2024.